Abstract
Photopheresis is a form of phototherapy where specialized equipment is used to isolate a leukocyte fraction from the peripheral blood which is then exposed to photoactivated 8-methoxypsoralen and reinfused into the patient. At the time of its invention the treatment was conceptually based on the hypothesis of T cell vaccination, i.e. the observation in experimental studies that exposure of the immune system to physically modified T cell clones leads to a specific inhibition of T cell mediated autoimmunity. Consequently, photopheresis has been tried in a variety of conditions where T cells are thought to have a critical role and has shown clinical efficacy mainly in variants of cutaneous T cell lymphomas, graft-versus-host disease, systemic sclerosis, in solid organ transplant rejection and Crohn‘s disease. Evidence has accumulated that alterations in antigen presentation and the generation of regulatory T cells are induced by photopheresis and might be related to the observed clinical effects. Summarizing what has been published in the 25 years since its introduction into the clinic, photopheresis to date has found its place in the treatment of the above mentioned conditions as a well tolerated treatment option that can safely be combined with other established modalities. It can be expected that further research will help refine its clinical indications and close the gaps that still exist in our knowledge on when, how, and why photopheresis works.
Similar content being viewed by others
References
R. L. Edelson, Photopheresis: a new therapeutic concept, Yale J. Biol. Med., 1989, 62, 565–577.
R. Knobler, M. L. Barr, D. R. Couriel, J. L. M. Ferrara, L. E. French, P. Jaksch, W. Reinisch, A. H. Rook, T. Schwarz, and H. Greinix, Extracorporeal photopheresis: past, present, and future, J. Am. Acad. Dermatol., 2009, 61, 652–665.
P. Szodoray, G. Papp, B. Nakken, M. Harangi, and M. Zeher, The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation, Autoimmun. Rev., 2012, 9, 459–464.
H. Hönigsmann, History of phototherapy in dermatology, Photochem. Photobiol. Sci., 2012. 10.1039/C2PP25120E.
F. Trautinger, Phototherapy of mycosis fungoides, Photodermatol. Photoimmunol. Photomed., 2011, 27, 68–74.
A. Ben-Nun, H. Wekerle, and I. R. Cohen, Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein, Nature, 1981, 292, 60–61.
O. Lider, T. Reshef, E. Beraud, A. Ben-Nun, and I. R. Cohen, Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis, Science, 1988, 239, 181–183.
P. A. Khavari, R. L. Edelson, O. Lider, F. Gasparro, H. L. Weiner, and I. R. Cohen, Specific vaccination against photoinactivated cloned T cells (abstract), Clin. Res., 1988, 36, 662A.
M. Perez, R. Edelson, L. Laroche, and C. Berger, Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes, J. Invest. Dermatol., 1989, 92, 669–676.
C. L. Berger, M. Perez, L. Laroche, and R. Edelson, Inhibition of autoimmune disease in a murine model of systemic lupus erythematodes induced by exposure to syngeneic photoactivated lymphocytes, J. Invest. Dermatol., 1990, 94, 52–57.
E. Ivancic, R. Knobler, P. Quehenberger, H. Hönigsmann, and F. Trautinger, The course of anticoagulation after extracorporeal photochemotherapy, Photodermatol. Photoimmunol. Photomed., 2005, 21, 150–151.
R. M. Knobler, F. Trautinger, W. Graninger, W. Macheiner, C. Grünwald, R. Neumann, and W. Ramer, Parenteral administration of 8-methoxypsoralen in photopheresis, J. Am. Acad. Dermatol., 1993, 28, 580–584.
C. Berger, K. Hoffmann, J. G. Vasquez, S. Mane, J. Lewis, R. Filler, A. Lin, H. Zhao, T. Durazzo, A. Baird, W. Lin, F. Foss, I. Christensen, M. Girardi, R. Tigelaar, and R. Edelson, Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy, Blood, 2010, 116, 4838–4847.
M. Girardi, J. Schechner, E. Glusac, C. Berger, and R. Edelson, Transimmunization and the evolution of extracorporeal photochemotherapy, Transfus. Apher. Sci., 2002, 26, 181–190.
A. Maeda, A. Schwarz, K. Kernebeck, N. Gross, Y. Aragane, D. Peritt, and T. Schwarz, Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells, J. Immunol., 2005, 174, 5968–5976.
M. Di Renzo, P. Rubegni, G. De Aloe, L. Paulesu, A. L. Pasqui, L. Andreassi, A. Auteri, and M. Fimiani, Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma, Immunology, 1997, 92, 99–103.
E. Gatza, C. E. Rogers, S. G. Clouthier, K. P. Lowler, I. Tawara, C. Liu, P. Reddy, J. L. M. Ferrara, Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells, Blood, 2008, 112, 1515–1521.
J. F. George, C. W. Gooden, L. Guo, and J. K. Kirklin, Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis, J. Heart Lung Transplant., 2008, 27, 616–622.
G. Papp, I. F. Horvath, S. Barath, E. Gyimesi, J. Vegh, P. Szodoray, and M. Zeher, Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis, Clin. Immunol., 2012, 142, 150–159.
M. Der-Petrossian, M. Födinger, R. Knobler, H. Hönigsmann, and F. Trautinger, Photodegradation of folic acid during extracorporeal photopheresis, Br. J. Dermatol., 2007, 156, 117–121.
F. Trautinger, R. M. Knobler, W. Macheiner, C. Grünwald, and M. Micksche, Release of oxygen-free radicals by neutrophils is reduced by photopheresis, Ann. N. Y. Acad. Sci., 1991, 636, 383–385.
U. Just, R. Knobler, G. Klosner, E. Ivancic-Brandenberger, H. Greinix, A. Becherer, and F. Trautinger, Leukocyte scintigraphy with 111In-oxine for assessment of cell trafficking after extracorporeal photopheresis, Exp. Dermatol., 2012, 21, 443–447.
R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, F. Grange, N. L. Harris, W. Kempf, H. Kerl, M. Kurrer, R. Knobler, N. Pimpinelli, C. Sander, M. Santucci, W. Sterry, M. H. Vermeer, J. Wechsler, S. Whittaker, C. J. L. M. Meijer, WHO-EORTC classification for cutaneous lymphomas, Blood, 2005, 105, 3768–3785.
R. Edelson, C. Berger, F. Gasparro, B. Jegasothy, P. Heald, B. Wintroub, E. Vonderheid, R. Knobler, K. Wolff, and G. Plewig, et al., Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results, N. Engl. J. Med., 1987, 316, 297–303.
J. A. Zic, The treatment of cutaneous T-cell lymphoma with photopheresis, Dermatol. Ther., 2003, 16, 337–346.
R. Knobler, and C. Jantschitsch, Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma, Transfus. Apher. Sci., 2003, 28, 81–89.
F. Trautinger, R. Knobler, R. Willemze, K. Peris, R. Stadler, L. Laroche, M. D‘Incan, A. Ranki, N. Pimpinelli, P. Ortiz-Romero, R. Dummer, T. Estrach, and S. Whittaker, EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome, Eur. J. Cancer, 2006, 42, 1014–1030.
J. J. Scarisbrick, P. Taylor, U. Holtick, Y. Makar, K. Douglas, G. Berlin, E. Juvonen, S. Marshall and G. Photopheresis Expert, U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease, Br. J. Dermatol., 2008, 158, 659–678.
J. A. Zic, Photopheresis in the treatment of cutaneous T-cell lymphoma: current status, Curr. Opin. Oncol., 2012, 24 Suppl 1, S1–S10.
F. Garban, S. Carras, P. Drillat, M. C. Jacob, B. Fabre, M. Callanan, S. Courby, C. Makowski, J. Y. Cahn, and R. Gressin, Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia, Ann. Oncol., 2012. 10.1093/annonc/mds014.
C. Charles, P. Clements, and D. E. Furst, Systemic sclerosis: hypothesis-driven treatment strategies, Lancet, 2006, 367, 1683–1691.
T. Ohtsuka, H. Okita, A. Yamakage, and S. Yamazaki, The effect of extracorporeal photochemotherapy on alpha1(i) and alpha1(iii) procollagen mRNA expression in systemic sclerosis skin tissue, Arch. Dermatol. Res., 2002, 293, 642–645.
M. Hashikabe, T. Ohtsuka, and S. Yamazaki, Quantitative echographic analysis of photochemotherapy on systemic sclerosis skin, Arch. Dermatol. Res., 2005, 296, 522–527.
M. Fimiani, P. Rubegni, M. L. Flori, C. Mazzatenta, G. D‘Ascenzo, and L. Andreassi, Three cases of progressive systemic sclerosis treated with extracorporeal photochemotherapy, Arch. Dermatol. Res., 1997, 289, 120–122.
K. Krasagakis, E. Dippel, J. Ramaker, M. Owsianowski, and C. E. Orfanos, Management of severe scleroderma with long-term extracorporeal photopheresis, Dermatol., 1998, 196, 309–315.
R. R. Muellegger, A. Hofer, W. Salmhofer, H. P. Soyer, H. Kerl, and P. Wolf, Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis. An Austrian single-center study, Photodermatol. Photoimmunol. Photomed., 2000, 16, 216–223.
A. H. Rook, B. Freundlich, B. V. Jegasothy, M. I. Perez, W. G. Barr, S. A. Jimenez, R. L. Rietschel, B. Wintroub, M. B. Kahaleh, and J. Varga, et al., Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial, Arch. Dermatol., 1992, 128, 337–346.
D. N. Enomoto, J. R. Mekkes, P. M. Bossuyt, S. L. Yong, T. A. Out, R. Hoekzema, M. A. de Rie, P. T. Schellekens, I. J. ten Berge, C. A. de Borgie, and J. D. Bos, Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis), J. Am. Acad. Dermatol., 1999, 41, 9159-9122.
R. M. Knobler, L. E. French, Y. Kim, E. Bisaccia, W. Graninger, H. Nahavandi, F. J. Strobl, E. Keystone, M. Mehlmauer, A. H. Rook, I. Braverman and G. Systemic Sclerosis Study, A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis, J. Am. Acad. Dermatol., 2006, 54, 793–799.
J. L. M. Ferrara, J. E. Levine, P. Reddy, and E. Holler, Graft-versus-host disease, Lancet, 2009, 373, 1550–1561.
H. T. Greinix, B. Volc-Platzer, P. Kalhs, G. Fischer, A. Rosenmayr, F. Keil, H. Hönigsmann, and R. M. Knobler, Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study, Blood, 2000, 96, 2426–2431.
H. T. Greinix, R. M. Knobler, N. Worel, B. Schneider, A. Schneeberger, P. Hoecker, M. Mitterbauer, W. Rabitsch, A. Schulenburg, and P. Kalhs, The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease, Haematologica, 2006, 91, 405–408.
E. Calore, A. Calo, G. Tridello, S. Cesaro, M. Pillon, S. Varotto, M. V. Gazzola, R. Destro, P. Marson, L. Trentin, M. Carli, and C. Messina, Extracorporeal photochemotherapy may improve outcome in children with acute GVHD, Bone Marrow Transplant., 2008, 42, 421–425.
H. T. Greinix, B. Volc-Platzer, W. Rabitsch, B. Gmeinhart, C. Guevara-Pineda, P. Kahls, J. Krutmann, H. Hönigsmann, M. Ciovica, and R. M. Knobler, Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease, Blood, 1998, 92, 3098–3104.
F. M. Foss, G. M. DiVenuti, K. Chin, K. Sprague, H. Grodman, A. Klein, G. Chan, K. Stiffler, and K. B. Miller, Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors, Bone Marrow Transplant., 2005, 35, 1187–1193.
N. Apisarnthanarax, M. Donato, M. Korbling, D. Couriel, J. Gajewski, S. Giralt, I. Khouri, C. Hosing, R. Champlin, M. Duvic, and P. Anderlini, Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results, Bone Marrow Transplant., 2003, 31, 459–465.
D. R. Couriel, C. Hosing, R. Saliba, E. J. Shpall, P. Anderlini, B. Rhodes, V. Smith, I. Khouri, S. Giralt, M. de Lima, Y. Hsu, S. Ghosh, J. Neumann, B. Andersson, M. Qazilbash, S. Hymes, S. Kim, R. Champlin, and M. Donato, Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD, Blood, 2006, 107, 3074–3080.
M. E. D. Flowers, J. F. Apperley, K. van Besien, A. Elmaagacli, A. Grigg, V. Reddy, A. Bacigalupo, H.-J. Kolb, L. Bouzas, M. Michallet, H. M. Prince, R. Knobler, D. Parenti, J. Gallo, and H. T. Greinix, A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease, Blood, 2009, 112, 2667–2674.
D. Wolff, M. Schleuning, S. von Harsdorf, U. Bacher, A. Gerbitz, M. Stadler, F. Ayuk, A. Kiani, R. Schwerdtfeger, G. B. Vogelsang, G. Kobbe, M. Gramatzki, A. Lawitschka, M. Mohty, S. Z. Pavletic, H. Greinix, and E. Holler, Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease, Biol. Blood Marrow Transplant., 2011, 17, 1–17.
E. A. Rose, M. L. Barr, H. Xu, P. Pepino, M. P. Murphy, M. A. McGovern, A. J. Ratner, J. F. Watkins, C. C. Marboe, and C. L. Berger, Photochemotherapy in human heart transplant recipients at high risk for fatal rejection, J. Heart Lung Transplant., 1992, 11, 746–750.
M. Wieland, V. L. Thiede, R. G. Strauss, W. W. Piette, D. P. Kapelanski, S. K. Landas, L. G. Hunsicker, S. J. Vance, and M. J. Randels, Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy, J. Clin. Apheresis, 1994, 9, 171–175.
R. Dall‘Amico, U. Livi, A. Milano, G. Montini, B. Andreetta, L. Murer, G. Zacchello, G. Thiene, D. Casarotto, and F. Zacchello, Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection, Transplantation, 1995, 60, 454–459.
R. Dall‘Amico, G. Montini, L. Murer, B. Andreetta, G. Zacchello, A. Gambino, G. Feltrin, A. Caforio, V. Tursi, and U. Livi, Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection, Int. J. Artif. Organs, 2000, 23, 49–54.
M. S. Lehrer, A. H. Rook, J. E. Tomaszewski, and D. DeNofrio, Successful reversal of severe refractory cardiac allograft rejection by photopheresis, J. Heart Lung Transplant., 2001, 20, 1233–1236.
M. L. Barr, C. J. Baker, F. A. Schenkel, S. N. McLaughlin, B. C. Stouch, V. A. Starnes, and E. A. Rose, Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation, Clin. Transplant., 2000, 14, 162–166.
M. L. Barr, B. M. Meiser, H. J. Eisen, R. F. Roberts, U. Livi, R. Dall‘Amico, R. Dorent, J. G. Rogers, B. Radovancevic, D. O. Taylor, V. Jeevanandam, and C. C. Marboe, Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group, N. Engl. J. Med., 1998, 339, 1744–1751.
J. K. Kirklin, R. N. Brown, S. T. Huang, D. C. Naftel, S. M. Hubbard, B. K. Rayburn, D. C. McGiffin, R. B. Bourge, R. L. Benza, J. A. Tallaj, L. J. Pinderski, S. V. Pamboukian, J. F. George, and M. Marques, Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis, J. Heart Lung Transplant., 2006, 25, 283–288.
M. B. Marques, and H. H. Tuncer, Photopheresis in solid organ transplant rejection, J. Clin. Apheresis, 2006, 21, 72–77.
T. Dani, and R. Knobler, Extracorporeal photoimmunotherapy-photopheresis, Front. Biosci., 2009, 14, 4769–4777.
D. M. Ward, Extracorporeal photopheresis: how, when, and why, J. Clin. Apheresis, 2011, 26, 276–285.
P. Wolf, D. Georgas, N. S. Tomi, C. M. Schempp, A. Bretterklieber, K. Hoffmann, Photochem. Photobiol. Sci. 10.1039/C2PP25203A, in press.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of a themed issue on current topics in photodermatology.
Rights and permissions
About this article
Cite this article
Trautinger, F., Just, U. & Knobler, R. Photopheresis (extracorporeal photochemotherapy). Photochem Photobiol Sci 12, 22–28 (2013). https://doi.org/10.1039/c2pp25144b
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c2pp25144b